Skip to main content
    E

    EyePoint, Inc (EYPT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.31
    +0.00 (+0.52%)

    Market Cap: $34.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    EyePoint, Inc (EYPT) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    EyePoint reported revenue of $31.37M for the fiscal year ended Dec 31, 2025, down 27.5% from the year before. That year, net income was -$231.96M with a net margin of -739.4%, operating cash flow was -$240.11M and free cash flow was -$243.39M. The quarter ended Sep 30, 2026 had revenue of $756.00K and net income of -$95.61M.

    Revenue and Margins

    Over the 8 years to Dec 2025, revenue grew from $7.54M, a compound annual rate of 19.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$31.37M-27.5%93.4%-776.0%-739.4%
    Dec 2024$43.27M-6.0%100.0%-337.1%-302.4%
    Dec 2023$46.02M+11.1%100.0%-163.1%-153.8%
    Dec 2022$41.40M+12.1%79.9%-240.6%-247.0%
    Dec 2021$36.94M-46.4%77.9%-149.6%-158.1%
    Dec 2020$68.87M+238.2%91.5%-54.1%-65.9%
    Dec 2019$20.36M+345.5%86.8%-235.0%-278.9%
    Dec 2018$4.57MN/A100.0%-853.6%-1884.2%
    Jun 2018$2.96MN/A100.0%-887.3%-1795.7%
    Dec 2017$7.54MN/A100.0%-246.4%-245.2%
    Annual, fiscal years ended Dec 2017 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Jun 2018Dec 2017
    Revenue$31.37M$43.27M$46.02M$41.40M$36.94M$68.87M$20.36M$4.57M$2.96M$7.54M
    Cost of revenue$2.07M$0$0$8.33M$8.18M$5.82M$2.69M$0$0$16.18M
    Gross profit$29.30M$43.27M$46.02M$33.08M$28.76M$63.05M$17.68M$4.57M$2.96M$7.54M
    Research and development$221.04M$132.93M$64.66M$49.64M$28.50M$17.42M$15.37M$18.50M$16.18M$14.88M
    Operating income-$243.43M-$145.85M-$75.07M-$99.64M-$55.28M-$37.29M-$47.86M-$39.02M-$26.27M-$18.58M
    Net income-$231.96M-$130.87M-$70.80M-$102.25M-$58.42M-$45.39M-$56.79M-$86.13M-$53.17M-$18.48M
    EBITDA-$234.17M-$135.18M-$68.51M-$95.62M-$51.59MN/A-$43.61M-$36.99MN/A-$17.76M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$756.00K$507.00K$696.00K$619.00K$966.00K$5.33M$24.45M$11.59M$10.52M$9.48M$11.68M$14.03M
    Gross profit$756.00K$507.00K$696.00K-$1.45M$245.00K$5.17M$23.65M$13.08M$9.79M$9.48M$10.93M$17.66M
    Operating income-$96.88M-$97.38M-$87.23M-$70.34M-$62.02M-$62.23M-$48.84M-$45.24M-$32.75M-$34.55M-$33.32M-$16.35M
    Net income-$95.61M-$94.47M-$84.83M-$67.61M-$59.73M-$59.43M-$45.20M-$41.40M-$29.36M-$30.83M-$29.28M-$14.10M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, the balance sheet showed $101.82M in cash and equivalents and no debt.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Jun 2018Dec 2017
    Total assets$364.00M$418.46M$355.18M$180.36M$263.37M$91.72M$72.97M$78.17M$78.17M$18.68M
    Current assets$328.65M$383.31M$344.80M$172.81M$237.75M$63.12M$41.72M$47.60M$47.60M$17.74M
    Cash and equivalents$101.82M$99.70M$281.26M$95.63M$178.59M$44.91M$22.21M$45.26M$45.26M$16.90M
    Total liabilities$57.88M$81.96M$88.86M$83.99M$78.99M$73.18M$64.64M$40.53M$40.53M$5.34M
    Short-term debt$0$0$0$10.47M$0$8.45M$481.00K$30.00KN/A$17.31M
    Long-term debt$0$0$0$29.31M$36.56M$37.98M$47.22M$17.62M$17.62M$17.31M
    Shareholder equity$306.11M$336.50M$266.32M$96.37M$184.38M$18.54M$8.33M$37.63M$37.63M$13.34M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$166.14M$228.19M$288.22M$364.00M$251.69M$301.15M$362.56M$418.46M$300.92M$324.25M$329.25M$355.18M
    Total liabilities$57.63M$61.78M$57.74M$57.88M$51.51M$55.14M$64.17M$81.96M$82.18M$95.94M$79.31M$88.86M
    Cash and equivalents$83.21M$110.46M$77.71M$101.82M$74.58M$71.14M$85.16M$99.70M$79.83M$90.77M$271.01M$281.26M
    Shareholder equity$108.51M$166.41M$230.47M$306.11M$200.18M$246.01M$298.40M$336.50M$218.73M$228.31M$249.93M$266.32M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Jun 2018Dec 2017
    Operating cash flow-$240.11M-$126.23M$1.88M-$65.00M-$50.10M-$14.44M-$56.70M-$21.91M-$21.91M-$20.49M
    Capital expenditures$3.28M$4.05M$3.48M$2.15M$156.00K$362.00K$213.00K$108.00K$108.00K$147.00K
    Free cash flow-$243.39M-$130.28M-$1.61M-$67.16M-$50.25M-$14.80M-$56.91M-$22.02M-$22.02M-$20.64M
    Share repurchases$543.00K$672.00K$451.00K$599.00K$0N/AN/AN/AN/AN/A
    Investing cash flow$68.58M-$219.35M-$3.31M-$17.27M-$33.12M-$362.00K-$213.00K-$16.89M-$16.89M$13.58M
    Financing cash flow$173.65M$164.02M$187.07M-$690.00K$216.90M$37.49M$33.86M$60.67M$60.67M$8.50M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$86.82M-$62.35M-$80.55M-$65.05M-$59.35M-$62.59M-$53.12M-$35.85M-$39.03M-$20.18M-$31.17M-$23.11M
    Capital expenditures$1.21M$1.20M$997.00K$986.00K$798.00K$1.22M$276.00K$384.00K$1.57M$900.00K$1.19M$883.00K
    Free cash flow-$88.02M-$63.55M-$81.55M-$66.03M-$60.15M-$63.81M-$53.40M-$36.23M-$40.60M-$21.08M-$32.37M-$23.99M
    Last 12 quarters

    Frequently Asked Questions About EYPT

    What is EyePoint's annual revenue?

    EyePoint reported revenue of $31.37M for the fiscal year ended Dec 31, 2025.

    How fast is EyePoint's revenue growing?

    Revenue was down 27.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -8.8%.

    Is EyePoint profitable?

    No. EyePoint reported net income of -$231.96M for the fiscal year ended Dec 31, 2025, with a net margin of -739.4%.

    How much free cash flow does EYPT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$240.11M minus capital expenditures of $3.28M produced free cash flow of -$243.39M.

    How much debt does EyePoint have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $0 and cash and equivalents of $101.82M.